Skip to main content
Clinical Trials/NCT04775940
NCT04775940CompletedNot Applicable

The Use of Perforated Barrier Membranes and IPRF Nano- Micro Sticky Bone in Horizontal Alveolar Ridge Augmentation - Controlled Clinical and Histomorphometric Study

Ain Shams University1 site in 1 country20 target enrollmentStarted: March 1, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
20
Locations
1
Primary Endpoint
Horizontal alveolar bone width in mm

Study Overview

Brief Summary

Comparing amount of horizontal bone gain 4 months after alveolar ridge augmentation using IPRF Nano- micro Sticky Bone with perforated collagen membrane versus occlusive barrier membrane by :

  1. clinical and Radiographic analysis .
  2. Histomorphometric analysis .

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
20 Years to 40 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Healthy adult patients.
  • •Both sex, males and females. 3-Age from 20 - 40 years old. 4-All patients will be free from any systemic diseases as evidenced by Burkett's oral medicine health history questionnaire.
  • •5-Remaining alveolar bone ≥ 8mm vertically and ≤ 4 mm horizontally. 6-Gingival biotype 1-2mm thickness.

Exclusion Criteria

  • •Pregnant and breast feeding females.
  • •Mentally retarded Patients.
  • •Presence of hematologic disease.
  • •Previous radiation, chemotherapy, or immunosuppressive treatments.
  • •Diabetes mellitus, metabolic bone disease, ongoing treatment with bisphosphonates drugs, or pregnancy.
  • •Anticoagulant drugs, Endocarditis risk factors, renal and hepatic failure

Arms & Interventions

Perforated collagen membrane

Experimental

Intervention: Perforated collagen membrane (Procedure)

Occlusive collagen membrane

Active Comparator

Intervention: Occlusive collagen membrane (Procedure)

Outcomes

Primary Outcomes

Horizontal alveolar bone width in mm

Time Frame: 6 months

Measured By Bone caliber and Cone Beam Computed Tomography (CBCT)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials